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Abstract
Background: Current ChIP-seq studies are interested in comparing multiple epigenetic profiles across several cell
types and tissues simultaneously for studying constitutive and differential regulation. Simultaneous analysis of multiple
epigenetic features in many samples can gain substantial power and specificity than analyzing individual features
and/or samples separately. Yet there are currently few tools can perform joint inference of constitutive and differential
regulation in multi-feature-multi-condition contexts with statistical testing. Existing tools either test regulatory variation
for one factor in multiple samples at a time, or for multiple factors in one or two samples. Many of them only
identify binary rather than quantitative variation, which are sensitive to threshold choices.
Results: We propose a novel and powerful method called dCaP for simultaneously detecting constitutive and
differential regulation of multiple epigenetic factors in multiple samples. Using simulation, we demonstrate the
superior power of dCaP compared to existing methods. We then apply dCaP to two datasets from human and
mouse ENCODE projects to demonstrate its utility. We show in the human dataset that the cell-type specific
regulatory loci detected by dCaP are significantly enriched near genes with cell-type specific functions and disease
relevance. We further show in the mouse dataset that dCaP captures genomic regions showing significant signal
variations for TAL1 occupancy between two mouse erythroid cell lines. The novel TAL1 occupancy loci detected only
by dCaP are highly enriched with GATA1 occupancy and differential gene expression, while those detected only by
other methods are not.
Conclusions: Here, we developed a novel approach to utilize the cooperative property of proteins to detect
differential binding given multivariate ChIP-seq samples to provide better power, aiming for complementing existing
approaches and providing new insights in the method development in this field.
Background
A central problem in molecular biology is to understand
how proteins and DNA interact to regulate genes that lead
to phenotypic diversity. Given massively parallel second
generation sequencing technologies [1-3], huge collection
of data are being generated for a wide diversity of regula-
tory elements genome-wide (such as transcription factors,
epigenetic marks, genetic variants, DNaseI hypersensitiv-
ity, and transcriptomes). The huge datasets enable us to
comprehensively study the mechanics of gene regulation
among multiple factors across many cell types and experi-
mental conditions simultaneously [4,5]. Key regulators
functioning in specific cells/conditions and their impacts
to gene expression can therefore be pinpointed with sub-
stantially improved power and specificity than conven-
tional approaches [6,7]. New hypotheses about the
dynamics of the epigenetic landscape during differentia-
tion can consequently be derived and tested to illuminate
previously intractable issues in the genetics of disease sus-
ceptibility [7-9].
How to effectively analyze the huge collection of epige-
netic data sets is a major challenge. Many computational
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methods have been developed to make binary presence-
absence calls for detecting protein-DNA interaction events
in a single condition [10-13], which are then used in down-
stream analysis to study gene regulation and differentiation
[14,15]. Although the binary calls of interaction events,
such as transcription factor (TFs) binding, have been
shown to aid the study in gene regulation, such an
approach is problematic because the same event may be
called differently due to the choice of thresholds and the
data scale in different samples. Alternatively, quantitative
methods (e.g. ANOVA) [16] have been used to study differ-
ential or condition-specific binding variations. Such an
approach is often overly simplistic that does not account
for the possible heterogeneity in the real data. When there
are few replication data available, it is also difficult to obtain
good estimates of the heterogeneous variance of the noise,
which then greatly reduces the sensitivity of the study.
More recent approaches have been developed to quan-
tify binding variations among multiple features or samples
[16-20]. Kasowski et al. used pairwise ANOVA to study
the genome-wide binding strengths of POL2 and NFkap-
paB between each pair of the 10 individuals at merged
binding regions [16]. In addition to using traditional statis-
tical tests, some other studies adopted methods developed
previously to identify differential expressed genes to detect
differential bindings in ChIP-seq experiments [21]. For
example, a gene stability measure M was defined by Van-
desompele et al. as the average pairwise standard deviation
between any particular gene and all other genes [22]. Ozer
et al. adapted the stability measure to determine most vari-
able regions binding regions across all 50 ChIP-seq experi-
ments. However, this stability measure does not provide a
measure for statistical significance and it’s also difficult to
interpret the value M across different experiments. Taslim
et al. developed DIME that takes normalized differences of
ChIP-seq counts in each genomic bin as input and used a
finite mixture model (non-differential, negative/positive
differential) to identify genes with differential binding for a
specific protein in two conditions [18,19]. Instead of using
genomic bins in Taslim et al. for normalization, Shao et al.
[23] later proposed a method called MAnorm to improve
data normalization in ChIP-enriched regions (peaks) based
on the assumption that most common peaks have the
same binding strength to build the rescaling model similar
to DIME. They used a Bayesian model developed for
detecting differential gene expression to determine the sig-
nificance of differential binding [24]. While DIME and
MAnorm have been developed for comparing binding sig-
nals for a single protein, a more recent method dPCA [25]
uses a small number of principle components to summar-
ize the pattern of difference in multiple proteins between
two samples.
These methods, however, are limited to two-sample
comparisons. As the number of conditions increases, pair-
wise comparison will become computationally expensive.
Combining and interpreting the data from pairwise results
can also be inconsistent. To overcome the limitation of
pairwise comparison, DBChIP was recently developed to
allow comparison in multiple conditions [17]. The method
first clusters nearby predicted binding sites into consensus
sites across multiple conditions, and then uses a general-
ized linear model with Negative Binominal distribution to
detect differential TF binding across samples. DBChIP
however only considers one protein at a time. Biologically,
protein-DNA interactions are correlated among regulators.
Combined patterns of signals for different epigenetic fea-
tures can provide more insights towards the regulatory
mechanisms in cells. A most recent method, jMOSAiC
[20], jointly analyzes multiple epigenetic features in multi-
ple samples. jMOSAiC internally partitions signals into
presence or absence events, and hence only detects quali-
tative variation.
In need of a systematic, powerful and flexible method
for simultaneous integration and comparison of ChIP-seq
data for multiple epigenetic features in multiple condi-
tions, we introduce a unified method, dCaP (Differentia-
tion among Conditions and Proteins), to detect and
quantify protein-DNA interaction events and their
Table 1 Proportions of TAL1 differential binding in the three categories overlapping with relevant biological features.
A. binary-only B. cap-only C. common
induced genes1 18.77% *** 32.83% 26.20%
repressed genes1 9.85% 9.94% 6.89%
all differential expressed genes1 28.62% *** 42.76% 33.09%
non-differential expressed genes1 52.08% 49.46% 50.75%
GATA1 binding peaks2 36.03% *** 95.68% 63.17%
GATA motifs3 66.27% *** 86.61% 59.51%
CpG islands4 2.39% 3.67% 2.19%
SNPs4 84.52% ** 89.42% 82.23%
Significance of difference in proportions between group A and B is denoted by * for each biological feature examined. ** denotes p-values between 5e-2 and
5e-3. *** denotes p-values < 5e-3. The p-values were obtained from the Fisher’s Exact Test. The differential expressed genes in G1E and G1E-ER4 were obtained
from the transcriptome data in G1E and G1E-ER4 cells1 [15]. GATA1 binding peaks were obtained from [15]. GATA motifs3 were identified by MEME relevant tools
[49]. Annotation data such as CpG islands4 and SNPs4 (dbSNP 128) were from database of UCSC genome browser [50].
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variations by treating multiple tracks of features as multi-
variate samples sequenced in multiple conditions. Here, a
“condition” can be an experimental condition, or more
broadly, a tissue, a cell type, or a sample with phenotypes.
dCaP uses locally weighted smoothing to estimate the het-
erogeneous variance of noises in the data, such that it is
free from the unrealistic constant variance assumption,
but at the same time it retains power even for small sam-
ple experiments. dCaP can work with or without repli-
cates. After normalization, dCaP utilizes a three-step log-
likelihood ratio test (Figure 1) to jointly identify multiple
protein-DNA interaction events in multiple conditions
genome-wide, detect regions with significant signal varia-
tions in at least one feature across conditions, and classify
the detected regulatory loci for condition-specificity.
While existing methods detect condition-specific events
via binary calls, dCaP detects quantitative variations.
We applied dCaP to two real studies to demonstrate the
power and the utility of dCaP. The first data set consists of
30 data tracks (of ChIP-seq and DNase-seq) from the
human ENCODE consortium. We chose five human cell
lines: GM12878, HUVEC, HeLa-S3, HepG2, K562; and
three regulatory factors in each cell line: transcription fac-
tor CTCF, RNA polymerase II (POL2) and DNaseI sensi-
tivity of the chromatin (DHS) [5]. Each factor in each cell
type has 2 replicates. By applying dCaP, we identified
194,840 statistically significant occupancy regions gen-
ome-wide, among which 33,205 contained differential sig-
nals and 16,452 were further cell-type specific. Clustering
analysis revealed two major clusters of occupancy patterns
in the five cell lines. One cluster showed consistently
enriched signals for all three factors and they were
enriched near genes showing functions highly relevant to
each of the cell types. The other cluster showed depleted
signals for all three factors and they were strongly asso-
ciated with homozygous deletions in the three cancer cell
lines (HeLa-S3, HepG2, K562). The results by dCaP
indicated potential regulatory regions responsible for cell-
type specific biological behaviours. We further applied
dCaP to detect differential TAL1 occupancy in response
to GATA1 restoration in two mouse erythroid cell lines.
Conventional approaches use peak callers (6) to identify
binary binding events in each cell line separately and then
take the difference between cell lines. Such solutions are
sensitive to the peak calling thresholds and cannot detect
quantitative variation in TAL1 occupancy. Using dCaP, we
identified a large set of novel differential TAL1 occupancy
missed by the binary peak calling method, and they were
highly significantly associated with GATA1 occupancy as
well as differential gene expression. dCAP is simple but
powerful. It can be widely applied to many studies for




Human ENCODE Data: Mappings of short reads of
CTCF, POL2 and DNaseI to the human genome (hg18)
were collected from the ENCODE open chromatin data
from the Duke/UNC/UT-Austin/EBI ENCODE group
for 5 selected cell lines [5]. The five chosen cell lines
are: K562 erythroleukemia cells [26], HeLa-S3 cervical
carcinoma cells [27], HepG2 hepatoblastoma cells [28],
GM12878, a B-lymphoblastoid cell line (http://1000gen-
omes.org) and primary (non-transformed) human umbi-
lical vein endothelial cells (HUVEC) [29]. Among the 5
cell lines, the first three are cancer cell lines and the last
two are relatively normal cell lines. We used two repli-
cates in each of the 15 data types (5 cell lines × 3 fac-
tors), resulting in 30 tracks of data in total.
Mouse ENOCDE Data: we obtained read counts by the
ChIP-seq experiments of TAL1 in two mouse erythroid
cell lines (G1E, G1E-ER4) from Wu et al. [15,30]. Each cell
line contains two data replicates. The union of TAL1 bind-
ing peaks reported from Wu et al. [15] in the two condi-
tions were used to detect the differential binding by dCaP.
The cell line G1E is derived from in vitro differentiated
Gata1-null mouse ES cells, proliferates as committed ery-
throid progenitors and undergoes terminal differentiation
upon restoration of Gata1 expression [15] and its subline
G1E-ER4 expresses an estrogen-activated Gata1-estrogen
receptor (ER) transgene.
Data pre-processing
Human ENCODE Data: We used F-Seq [31] to generate
continuous tag sequence density estimation in 1-bp reso-
lution for all 30 data tracks. We then computed the sum
of tag sequence density in 1-kb tiled windows across the
human genome for hypothesis testing of common and dif-
ferential occupancy across cell lines. Blacklist regions from
UCSC assembly gaps and the Duke excluded regions were
Figure 1 Flow chart of dCaP.
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found to have the anomalous high signals and thus
excluded in our analysis. This resulted in 2,821,390 win-
dows for testing across the human genome, excluding the
Y chromosome. We further took log2-transformed density
to reduce the skewness of the data. A small constant (0.1)
was added to the value when taking the log2 to avoid
numerical problems. Based on the log2 density values in 1-
kb windows, we further performed quantile-normalization
[32] on the 10 data tracks (5 cell lines, 2 replicates) for
each factor to make datasets across cell types comparable.
The quantile normalization does not necessarily
remove the systematic bias within replicates. We further
applied LOESS (locally weighted regression) normaliza-
tion [33] on the log2 transformed density of each data
track. Let x(i)j,k,r denote the data value in window i, cell
line j, factor k and replicate r, and let x¯(i)k denote the
mean of factor k across all cell lines and replicates in
window i. We applied LOESS function by regressing
(x(i)j,k,r − x¯(i)k ) on the factor mean x¯(i)k , for data in all win-
dows in each data track. The LOESS estimate x˜(i)j,k,r was
then subtracted from x(i)j,k,rso that the new values (at the
same level of x¯(i)k ) has mean 0 across windows. For large
datasets, LOESS computation can be slow, and the fitted
curve can be overly smooth or curvy at different values
using a fixed smoothness parameter. To increase com-
puting speed and to fit local curves better, we parti-
tioned the data values into bins and we subsampled data
with equal frequency from each bin. This prevented the
fitting curve being biased by the unbalanced data where
the data points were much denser at low signals and
sparser at high signals. We sampled 1% of the total data
using 25 bins and the maximum number of data points
per bin was bounded by the total number of sampled
points divided by the number of bins. For the LOESS
parameters, we used span = 0.5 with locally linear fit
(degree =1).
Mouse ENOCDE Data: we obtained the processed data
(the read counts) from Wu et al. (6). We took the aver-
age log2 value of the read counts within each detected
binding region and performed quantile-normalization.
The values were then used as the input to dCaP for test-
ing differential binding.
Method notations
We propose three log likelihood ratio tests (LRT) under
asymptotic multivariate normality assumption. For nota-
tion consistency, we use lowercase/uppercase bold let-
ters to denote vectors and matrices, respectively, and we
use uppercase regular letters for constants. Although
Negative Binomial distributions or other distributions
with over-dispersion parameters are often used for
modeling *-seq data, they cannot be easily adopted to
model the joint distribution of multivariate signals with
covariance structures. In our case, covariance is abun-
dant among related proteins, and multivariate normal
distributions can conveniently account for the covar-
iance among signals. Multivariate normality is also rea-
sonable when testing the means of samples over many
conditions, and when proper data transformation is
used on the *-seq data, such as log-transformation,
averaging signals over intervals, or quantile transforma-
tion to z-scores.
Let X(i) = (x(i)1,1, x
(i)




C,P) denote a C by P
data matrix containing log2-transformed signals after
proper normalization in C conditions with P variables,
for condition j = 1 ... C, variable p = 1 ... P, and win-
dows i = 1 ... N across the genome (C≥2, P≥1). For each
condition j in window i, the column vector x(i)j consists
of K factors with R replicates (K≥1, R≥1), and therefore




















We assume that each vector x(i)j follows a P-dim multi-




condition specific mean uˆ(i)j and a covariance matrix
∑ˆ(i)
j
in the ith window, for j = 1 ... C. The mean vector uˆ(i)j
has a restriction that the means of replicates of the
same factors are identical. We first estimate uˆ(i)j ,
∑ˆ(i)
j
along with uˆ(i)0 under the null hypotheses. We then use
log-likelihood ratio tests to detect potential common
and differential regulatory binding events across the
genome. Hereafter, we use “binding” to denote a pro-
tein-DNA interaction event, even though our method is
technically applicable to detect any signal enrichment
and variation in general.
Estimation of covariance matrix
To obtain the covariance matrix for condition j in window
i, we first estimate a condition specific (but not window
specific) correlation matrix Rˆj, which is a P by P matrix
that captures potential relationships between different fac-
tors and replicates. Let Xj denote the N by P data matrix
in condition j in all genomic windows. We want to com-
pute Rˆj = Cor(Xbkj ), where X
bk
j denotes a data matrix from
genomic background (e.g., no binding) and Cor(.) denotes
correlation. Since Xj contains a mixture of binding and
non-binding data and binding regions are unknown, esti-
mating background Xbkj from Xj is not straightforward.
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Directly estimating Rˆj by Cor(Xj)will lead to bias, because
the binding signals can greatly inflate the correlation
between factors/replicates.
Assume that Xj = Xbkj +m, where m denotes an
unknown vector of the means of binding signals indepen-










We estimate m by X¯j, which is an N by P matrix con-
taining the mean of each factor across conditions (the















the other hand, if input controls are available, Rˆj can be
obtained directly from the controls. When pre-defined
binding regions are available for directly testing differential
binding, Xj became a N by P data matrix containing the
binding signals in all binding regions in condition j. To
obtain Rˆj in this case, we first subtract mean of each factor
across conditions in each row, then we take the bottom
50% of rows ranked by the total variance of centred data
to calculate the correlation matrix.
Given Rˆj, we compute the window-specific covariance
matrix, which we assume to be a function of window























denotes a diagonal matrix in which
the diagonal entries are the estimated standard deviations











To estimate the standard deviation σˆ (i)jp for each of the P
variables in condition j, we assume that the variances of
replicates of the same factor are identical, and thus esti-
mating σˆ (i)jp for variables p = 1... P reduces to estimating
σˆ
(i)
j,k for factors k = 1...K.
For each factor k in each condition j, we calculated the
replicate mean x¯(i)j,k and the unbiased estimate of the var-
iance σ 2j,k
(i) of replicates in each window i. Due to possible
correlation between replicates, the commonly used sample
variance estimator may under estimate the true variance.
Instead, we used the following de-correlated values to





Here x(i)j,k is a vector of length R and Rˆj,k denotes a sub-
correlation matrix for replicates of factor k in condition j,
obtained from the full correlation matrix Rˆj. Chol(.)
denotes Cholesky decomposition.
We fitted a LOESS curve to the (x¯(i)j,k, σ
2
j,k
(i)) pair of all
windows using the same LOESS setting described pre-
viously in the normalization section. The fitted smooth
curve represents a function between replicate mean and
variance. At each window i, we estimated σˆ (i)j,k by the
square root of the fitted value given by the curve at x¯(i)j,k.








Log likelihood ratio tests
Test 1. Detect binding versus non-binding
We first detect binding events of any factor in any con-









against the alternative hypothesis H1: at least one u
(i)
j dif-





denote P-dim vectors of means, and we estimated u(i)bck as
the median signals across all conditions in the ±5kb neigh-
bourhood of window i, for each factor respectively.
Under a multivariate normal distribution, the MLE uˆ(i)j




where A denotes a P by K matrix of 0s and 1s. For
each column k = 1,..., K, there are R 1s in rows (k-1)r
+(1,..., R). uˆA(i)j is a column vector of length K containing
the means for K factors. Derivations of the MLE of uˆ(i)j
in equation (7) can be found in Additional File 1.






) to multivariate normal distribution and
computed maximum of the likelihoodsL(i)0 , L
(i)
1 under the
























∣∣∣∣∣− 12(x(i)j − uˆ(i)j )′∑ˆ(i)j −1(x(i)j − uˆ(i)j )
}
(9)
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. Then we can compute the likelihood ratio test






= 2(L(i)1 − L(i)0 ) (10)
Under the null hypothesis that there are no binding
events in window i of all factors in all conditions, T(i)
follows an asymptotic Chi-square distribution with CK
degrees of freedom. Note that this test is bi-directional,
i.e., both enriched and depleted binding signals relative
to the background can be detected. To detect enriched
signals only, we can replace x(i)j − uˆ(i)j by 0 whenever it
is negative.
Test 2. Detect differential binding versus common binding
To identify potential regulatory differential binding
regions across conditions, we performed a 2nd LRT test
on the null hypothesis H0:
H0 : u
(i)





against the alternative hypothesis H1: at least one u
(i)
j
differs from the rest, where u(i)0 denote the averaged
mean signals across conditions within window i (as
opposed to the ±5kb neighbourhood around window i
in the 1st test). While we used the same values of u(i)j as




Again, uˆA(i)0 is a column vector of length K containing
the means for K factors, and derivations of the MLE of
uˆA(i)0 in equation (12) can be found in Additional File 1.
The LRT statistic for the null hypothesis (11) has the same
form as (10), but with u(i)bck replaced by uˆ
(i)
0 in (8) and (9).
Under the null hypothesis that the binding (or non-bind-
ing) signals for all factors are consistent across conditions
in window i, the test statistic follows an asymptotic Chi-
square distribution with (C-1)K degrees of freedom.
Test 3. Identify condition specific binding
The p-values of our log likelihood ratio tests are given by
the tail probabilities of the chi-square distribution with CK
degrees of freedom for the 1st test and (C-1)K degrees of
freedom for the 2nd test, respectively. To call statistically
significant regulatory regions (1st test) and differential
binding regions (2nd test), we used Bonferroni correction
to adjust p-values and then used 0.05 as the cutoff. Only
the windows rejected by the 1st test are further tested by
the 2nd test. After the 2nd test calling significant regions
that have at least one condition showing differential
binding in at least one factor, we further want to evaluate
which regions have differential binding in one and only
one condition. To check if the differential binding event in
window i occurs only in condition j, we applied a 3rd test,
which is equivalent to the 2nd test but leaving out the data
in the current condition j, for all j = 1 ... C. We obtained
another statistics T(i)−j based on the log likelihood ratios
using data in only C-1 conditions.
T(i)−j = 2(L
(i)
0,−j − L(i)1,−j) (13)
The T(i)−j statistic can be treated as the deviance obtained
by the other conditions while leaving out j. Since we
already know that window i has differential binding sig-
nals, we can decide if the differential binding event only
occurs in condition j by checking the significance of T(i)−j.
In particular, we say that window i has differential binding
only in condition j if T(i)−j is the only statistics, compared to
the statistics for other conditions, with adjusted p-value >
0.05 in window i (i.e., insignificant only by removing the
data from j).
Data simulation
To evaluate the performance of our method, we applied
dCaP to a simulated dataset containing 30 data tracks
including 5 conditions, 3 factors in each condition, and
two replicates per factor. Each data track consists of
30,000 data points. Since the variances of the log2 signals
in the non-binding and binding regions in the human
ENCODE data set were about 4 and 1, respectively, we
used the same values in the simulation. For each data
track, non-binding background signals were sampled inde-
pendently from a normal distribution with mean 0 and
variance 4. We then randomly selected 1,800 windows as
binding regions in any of the five conditions, and we simu-
lated the binding signals from a normal distribution with
mean 8 and variance 1. Among the 1,800 binding win-
dows, 1,200 were simulated as common bindings that
appeared in all five cell lines and three factors. For the
remaining 600 bindings, we randomly assigned an integer
M (0<M<5) to each window and assigned binding signals
to all three factors in M out of the 5 conditions. As a
result, these 600 bindings can be treated as differential
bindings. Correlations among the three factors were also
simulated to mimic those observed in the human
ENCODE data. In addition to the simulated data described
above, we generated two more datasets in the same setting
except that we changed the mean and variance of the
binding signals to (6, 1.56) and (4, 2.25), respectively.
Accordingly, we call the three simulated datasets strong,
medium and weak binding data, respectively. As Negative
Binomial distribution was found to provide better fit to
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the count data in ChIP-seq experiments [34], we con-
ducted another simulation using data from Negative Bino-
mials. Details can be found in Additional File 2.
Results
Simulation study
Using the simulated data described in Methods, we first
evaluated the performance of dCaP Test 1 for joint peak
calling. We compared the results of dCaP Test 1 using 5
conditions together (dCaP-T1-all) with the union of the
results obtained from each condition separately (dCaP-
T1-single). Figure 2A shows the Receiver Operating
Characteristics (ROC) curves generated by dCaP-T1-all
and dCaP-T1-single for the three data sets at different
levels of binding strengths (strong, medium, weak). We
found that the performance of dCaP-T1-all is consistently
better than dCaP-T1-single at all levels of binding
strengths, indicating the power gain of joint peak calling
versus separate peak calling. Particularly, the power of
dCaP-T1-all (PRC 94.5%) is substantially better than the
merged results from dCaP-T1-single (PRC 85.8%) for the
weak binding data (dotted black and blue lines in Figure
2A).
We next evaluated the performance of dCaP Test2
(dCaP-T2-all) for detecting differential binding of multi-
ple factors in multiple conditions. We compared dCaP-
T2-all to multivariate analysis of variance (MANOVA)
and the resulting ROC curves are shown in Figure 2B.
Again, we observed that dCaP-T2-all is substantially
more powerful than MANOVA at all levels of binding
strengths. We further compared the performance of
dCaP-T2 in a two-sample-one-factor scenario (dCaP-T2-
pair) with ANOVA and DIME [18]. The ROC curves
(Figure 2C) again show that dCaP-T2-pair performs con-
sistently better than the other two methods at all levels
of binding strengths, and the performance of DIME is
better than ANOVA in the strong and weak binding
data. In addition to using simulated multivariate normal
data, we also compared the performance of dCaP-T2-all
with the above methods (ANOVA/MANOVA/DIME)
along with DBChIP using simulated Negative Binomial
data. Except for MANOVA/dCaP, the output statistics
for other methods were obtained from each pairwise
comparison on a single factor between all pairs of condi-
tions. After combining the pairwise statistics using Fish-
er’s method, we used ROC curve to compare their
performance. Detailed methods can be found in Addi-
tional File 2. Our findings showed that while dCaP-T2-
all, DIME, and DBChIP outperformed MANOAVA/
ANOVA at all levels of binding strengths, these three
methods performed equally well at the strong and med-
ium binding sites. For the weak binding sites, dCaP-T2-
all outperformed the others (Additional File 2 Figure S1).
Application to human ENCODE Data
By applying dCaP to the ENCODE data sets of three epi-
genetic factors (CTCF, Pol2, DNaseI) in five cell lines
(GM12878, HUVEC, HeLa-S3, HepG2, K562), we detected
194,840 (6.9% of all regions tested) significant occupancy
regions genome-wide (excluding chromosome Y) at Bon-
ferroni adjusted 0.05 significance level. Among those sig-
nificant regions, 33,205 (17% of 194,840) showed
differential signals of the 3 factors among the 5 cell lines.
Furthermore, 16,452 (49% of 33,205) of the differential
regions were cell-type specific. After merging the contigu-
ous regions, we obtained 13,858 cell-type specific intervals.
A majority of cell-type specific intervals have length 1-kb.
Yet, we found a set of signal-enriched regions with length
longer than 10 KB (Figure 3). These long cell-type specific
intervals were mostly due to the long span of POL2 sig-
nals, and they are consistent with the cell-type specific
gene expression (ENCODE RNA-Seq). Examples of these
regions include genes ASHG, AFP, GPC3 in HepG2 cell
line, THBS1 in HUVEC cell line, BC068609, LOC648232
and a 30 KB region close to 7q36.2 (starting from position
152,710,000 in hg18) in K562 cell line. We also observed
clusters of cell-type specific depleted signals in local inter-
vals, which were mostly due to large genomic deletions.
To explore the binding patterns in each group of the
cell-type specific regions, we centred the binding signals
of the 3 factors by their means across all cell types. We
then used these relative binding signals to perform K-
means clustering to the cell-type specific windows to
identify co-occupancy patterns of the 3 factors in the cor-
responding cell types. We varied the number of clusters
K from 2 to 12 and chose the optimal K using the
Calinski-Harabasz index, which evaluates the cluster
validity based on the average between- and within-cluster
sum of squares [35]. The clustering results showed that
each of the five groups of cell-type specific windows
mainly demonstrated two distinct patterns: one with
enriched signals of all 3 factors in the corresponding cell,
and the other with consistently depleted signals. To
visually examine the epigenetic signals in each group of
Figure 2 The ROC curves generated using simulated data at
different levels of binding strengths (strong, medium, weak).
(A) ROC curves of dCaP-T1-all and dCaP-T1-single. (B) ROC curves of
dCaP-T2-all and MANOVA (C) ROC curves of dCaP-T2-pair, DIME and
ANOVA.
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cell-type specific regions in each cluster, we generated
heatmaps of relative binding signals across cell types,
their corresponding copy number variations (CNVs,
ENCODE common cell CNV, HAIB Genotype Track
[36]), and scatter plots, in Figure 4 (A,B,C), respectively.
Cell-type specific depletion in tumor cell lines is associated
with CNVs
DNA copy number variation is a common genetic altera-
tion observed in solid tumors, and it contributes to tumor
evolution by alterations of the expression of genes within
the region [37]. As shown in Figure 4 (A, B), compared to
the normal cell lines, the cell-type specificity in the cancer
cell lines (HeLa-S3, HepG2 and K562) is strongly asso-
ciated with copy number variations of various kinds
(amplified, heterozygous deletion or homozygous deletion)
[36]. There are many more CNVs in the cancer cell lines
than in the two relatively normal cell lines. K562 has the
most CNVs with a genome-wide coverage of 715 Mb, and
the CNV coverage of HeLa-S3 and HepG2 are around 613
Mb and 550 Mb, respectively. In contrast, the CNV cover-
age in the two normal cell lines are both <5 Mb.
Consistent with the genome-wide CNV distribution,
37% of the K562-specific binding windows co-occurred
with the CNVs, which accounted for the most CNV over-
lap among the 5 groups of cell-type specific windows.
Among the 5 cell types, K562 also had the largest number
of depleted binding windows (364, 90.77%) overlapping
with homozygous deletions (Figure 4B). As expected,
homozygous deletions were only found in the cell-type
specific non-binding regions, but not in the enriched
regions. On the other hand, heterozygous deletions were
found in both enriched and depleted cell-type specific reg-
ulatory regions. In HeLa-S3 and K562 cell lines, heterozy-
gous deletions occurred 2-3 times more frequently in the
depleted binding regions than in the enriched ones. Con-
versely, there were 5 times more heterozygous deletions in
HepG2-specific enriched binding regions than in the
depleted ones.
Figure 5A shows an example of 342 K562-depleted win-
dows clustered (shown in olive) in a 10.8-MB region on
9p21.3-9p21.1, which were associated with 8 homozygous
deletions. These homozygous deletions spanned approxi-
mately 9-MB and the loss of DNA sequence in this region
has been previously observed in solid tumors and leukemia
[38,39]. Many genes in this region (e.g., the CDKN2A/
CDKN2B locus and MTAP) were found to be associated
with different types of cancer [40-42]. Owing to this large
deletion, we observed consistent depletion of CTCF, DHS,
POL2 signals in K562. In contrast, ENCODE called a few
Figure 3 Length distribution of cell-type specific enriched
binding (+) and depleted binding (-) segments. The symbol size
is proportional to the frequency of the corresponding segment
length.
Figure 4 Patterns of binding and CNV in the five groups of
cell-type specific regions identified by dCaP. (A) The five
heatmaps represent the five groups of cell-type specific regions
identified by dCaP. Each heatmap corresponds to one specific cell-
type. Each row in a heatmap shows a cell-type specific region and
each column shows the relative binding signals from one of the 15
data tracks. The first three columns are the relative binding signals
of the three factors (CTCF, DHS and POL2) in the GM12878 cell
lines. The remaining columns are ordered in the same way for
HUVEC, HeLa-S3, HepG2 and K562 cell lines, respectively. The rows
are first ordered by their clustering class (enriched/depleted) and
within each class, the cell-type specific regions are ordered by their
genomic locations. (B) Heatmap of CNVs in the five groups of cell-
type specific regions. The rows of the heatmap are arranged in the
same way as in A and the columns show different types of CNVs in
order of GM12878, HUVEC, HeLa-S3, HepG2 and K562. (C) Scatter
plots of K-means clustering on the relative binding signals of the
three factors in each group of cell-type specific regions.
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binding peaks in K562 cell lines (shown in dark blue in
Figure 5A) in this homozygous deletion region, which are
likely false positives.
Figure 5B shows another example of depleted cell-type
specific binding in HeLa-S3, which is located in gene locus
STK11/LKB1 with tumor suppressor function [43]. We see
that, in gene STK11, 7 binding regions (in purple), 4 differ-
ential binding regions (in green) and 3 cell-type specific dif-
ferential binding regions (in olive) were detected by dCaP.
One HeLa-S3 specific depleted binding region (in olive)
was observed near the transcription start site (TSS) of
STK11 and was found to be associated with a homozygous
deletion highlighted in red (Figure 5B). Furthermore, we
observed loss of RNA-Seq signals (ENCODE Caltech
RNA-Seq) in the first three exons of STK11 in HeLa-S3
cell lines (the last track of Figure 5B), which coincided with
the three cell-type specific differential binding regions
detected by dCaP. A recent study (29) reported that STK11
plays an important role in multiple cellular functions
including cell growth, cell cycle progression, metabolism,
cell polarity, and migration. STK11/LKB1 is a tumor
suppressor gene with lower expression in HeLa cell lines
(cervical cancer cells) [43]. Our results suggest that the
cell-type specific depleted binding in cancer cell lines may
be due to genomic deletions. The cell-type specific differ-
ential binding regions detected by dCaP in cancer cell lines
can pinpoint the regulatory loci that may undergo genetic
alterations, and hence their nearby target genes may be the
potential candidate genes associated with cancer.
Cell-type specific enriched binding are enriched for cell-type
specific functions
The functional categories detected using GREAT version
2.0.2 (great.stanford.edu) [44] revealed that our cell-type
specific intervals of enriched signals were significantly
associated with genes carrying cell-type specific functions.
We show the top 20 significant functional terms in Gene
Ontology (GO), Disease Ontology, Mouse Phenotypes,
Cancer Neighbourhoods and Pathway Commons in Figure
6. We associated each cell-type specific binding window to
its single nearest gene up to 1 Mb and required that the
significant terms satisfy both Binomial and Hypergeo-
metric FDR <5% and region fold enrichment >=2. The
-log10 Binomial FDRs were used to generate the heatmap
of the function annotation terms, where black denotes no
significant terms found by the above criteria. Below we
elaborate the enrichment analysis results for the cell-type
specific binding regions in each of the five cell lines, which
demonstrate strong evidence that dCaP can pinpoint the
genomic loci that play important roles in regulating cell-
type specific functions and diseases.
GM12878 (transformed human B-lymphocyte cell line):
GM12878-specific enriched (GM-enriched) binding win-
dows were found to be near genes with GO terms specially
in immune response, regulation of immune system pro-
cess, regulation of cell/lymphocyte/leukocyte/T-Cell acti-
vation, defense response, cellular response to cytokine
stimulus and cytokine mediated signaling pathway
(Figure 6A). In addition, the GM-enriched windows were
also close to genes in MHC class II receptor activity, SH3
domain binding (GO Molecular Function). An enrichment
analysis of Disease Ontology highlights many lymphoid
diseases, such as lymphoid cancer, lymphoma, lympho-
blastic leukemia and also other auto-immune diseases
(lupus erythematosus) (Figure 6B). Similar lymphoid/
immune related terms were also reported in Mouse Phe-
notypes (Figure 6C) and were highly related to the cell
type of GM12878. From the MSigDB Cancer Neighbour-
hood Ontology, we found that the GM-enriched binding
windows were in proximity to cancer-associated genes,
CD53, VAV1, INPP5D, STAT6, HLA-C, etc (Figure 6D).
GREAT also reported GM-enriched windows involved in
T cell/B cell activation (Panther Pathway), and GM-
enriched windows were close to genes involved in BCR,
TCR, PD-1 signaling, intestinal immune network for IgA
production, costimulation by the CD28 family, antigen
Figure 5 Examples of cell-type specific regions detected by
dCaP. (A) K562-specific depleted binding detected by dCaP (shown
in olive) associated with large homozygous deletions on
chromosome 9. (B) HeLa-specific depleted binding detected by
dCaP close to the TSS of gene STK11 (binding windows shown in
purple, differential binding in green and cell-type specific windows
in olive).
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processing and presentation, etc (MsigDB Pathway). There
were also other pathways specific to GM12878, for exam-
ples, cytokine signaling in immune system and interferon
alpha/beta/gamma signaling pathway (Figure 6E). An
enrichment analysis of HGNC Gene Families showed that
the GM-enriched windows were close to members of the
HLA and CD family. The InterPro Ontology also reported
that genes with immunoglobulin/major histocompatibility
conserved site, MHC class I/II antigen recognition protein
domain, and SH2 motif, were close to GM-enriched win-
dows. The Predicted Promoter Motifs ontology reveals
that the motifs of SPI1, ETV4, ELF1, IRF1 (IFN-regulatory
factor-1), RUNX1, ETV7, STAT1 (a key transcription fac-
tor in the interferon signaling pathway), and NFKB, were
found in the promoters of genes associated with GM-
enriched windows. This result suggests that the above TFs
could be potential co-regulators of genes near GM-
enriched windows.
HUVEC (umbilical vein endothelial cell line): The
enriched GO terms for HUVEC-enriched binding win-
dows were also relevant to its tissue type. Targets of the
HUVEC-specific enriched windows were found to be
enriched in angiogenesis, blood vessel, vasculature devel-
opment, blood vessel morphogenesis, and regulation of
endothelial cell migration, etc (Figure 6A). The disease
ontologies enriched in genes near HUVEC-enriched win-
dows highlighted many vascular-related diseases, including
arteriopathy, arteriosclerosis, diabetic angiopathy, eye dis-
eases (diabetic retinopathy) and heart diseases (Figure 6B).
The InterPro ontology also reported genes with the epi-
dermal growth factor-like type 3, EGF-like conserved site
near HUVEC-enriched windows. Enrichments from the
Pathway Commons ontology highlighted Beta3 integrin
cell surface interactions, VEGF specific signaling, and
many others (Figure 6E).
HeLa-S3 (cervical epithelial carcinoma cell line): The top
enriched GO terms for the HeLaS3-enriched windows
were associated with HeLa-S3’s epithelial cell type, such as
epithelium development, epithelial cell differentiation/
development and skin development. Other terms includ-
ing SMAD protein signal transduction and canonical Wnt
receptor signaling pathway were also found to be enriched
around the HeLa-enriched windows. Besides, a few GO
terms and mouse phenotypes related to vessel develop-
ment (vasculature development, blood vessel morphogen-
esis, abnormal angiogenesis, etc) were shared between
HeLa-S3, HUVEC, and HepG2 (Figure 6A, 6C). Since
HeLa-S3 is derived from a human cervix adenocarcinoma,
compared to GM12878 and HUVEC, we found that many
enriched disease phenotypes detected by GREAT in this
group were related to different types of cancer, including
bone, prostatic, urinary tract, pancreatic cancer (Figure
6B). Among those, papillary epithelial carcinoma was
found strongly associated to HeLa-S3.
HepG2 (hepatocellular carcinoma cell line): The HepG2
cell line is derived from a male with a well differentiated
hepatocellular carcinoma. Among the 5 cell types, we
observed that HepG2 has the largest number of enriched
binding windows (494, 41.24%) in the amplification CNVs.
The enriched GO terms of genes close to the HepG2-
enriched windows were unique from the other cell types.
Top enriched GO terms (Molecular Function) showed
enrichment in peptidase inhibitor/regulator activities,
enzyme inhibitor activities, and endopeptidase inhibitor/
regulator activities. The GO terms in Biological Process
show more detailed terms in regulation in the above activ-
ities and also including terms relevant to kidney develop-
ment, such as mesonephric tubule morphogenesis. (Figure
6A). Most of the top disease terms detected in HepG2-
enriched windows are all related to liver diseases, includ-
ing hepatoblastoma, liver cirrhosis, hepatitis, fatty liver,
hepatocellular carcinoma. GREAT also reported that
HepG2-enriched windows were close to many cancer
genes HPX, HPN, LCAT, TST, GSTM1, CEPBA, CYP2B6.
(Figure 6D). Unique pathways, such as FOXA2 and
FOXA3 transcription factor networks, Lipoprotein meta-
bolism (Pathway Commons) were also reported by
GREAT (Figure 6E). Among these pathways, the FOXA1,
FOXA2 and FOXA3 transcription factor networks were
reported to be expressed early in embryonic endoderm
and play important roles in the regulation of gene expres-
sion in liver and pancreas [45]. The MsigDB Predicted
Promoter Motifs ontology showed that HepG2-enriched
windows were close to genes whose promoters contain
binding sites for TCF1/HNF1 (hepatocyte nuclear factor
Figure 6 Functional enrichments from GREAT in the enriched
binding cluster of cell-type specific windows.
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1) and FOXA1/ HNF3a. The Transcription Factor Targets
ontology has compiled data from ChIP experiments that
link transcription factor regulators to downstream target
genes. GREAT revealed that the HepG2-enriched windows
were located near genes regulated by master regulators of
hepatocyte and islet transcription, such as HNF1a and
HNF4a in human liver and pancreatic islets (Binomial
FDR<2.4e-34) [46]. Furthermore, the strongest term in
MSigDB Perturbation ontology showed enrichment in
liver selective genes. Particularly, 16.34% of HepG2-
enriched windows were within the neighbourhoods of
liver genes. The HGNC Gene Families ontology also indi-
cated that 18 HepG2-enriched windows were located near
13/33 SERPIN gene families.
K562 (chronic myelogenous leukemia cell line): The tar-
gets of K562-specific binding windows were enriched in
Mouse Phenotypes, such as microcytosis, decreased ery-
throcyte/hematopoietic cell number, anemia, abnormal
homoglobin, abnormal iron hemostasis, etc (Figure 6C).
The MSigDB Cancer Neighborhood highlighted cancer-
associated genes, TAL1, ANK1, SPTB, SPTA1, PRDX2,
MAP2K3, etc. (Figure 6D). The MSigDB Perturbation
ontology also showed enrichment of the top 40 genes
from cluster 7 of acute myeloid leukemia (AML) expres-
sion profile in a previous study [47].
Application to mouse ENCODE data
We further applied dCaP Test 2 (dCaP-T2) to detect dif-
ferential TAL1 occupancy before and after restoration of
GATA1 in two mouse erythroid cell lines (G1E, G1E-ER4)
reported in Wu et. al [15]. Since TAL1 and GATA1 are
critical erythroid transcription factors and often co-bind
during erythroid differentiation, studying the differential
binding of TAL1 in these two cell lines allows us to under-
stand the mechanisms of erythroid gene induction and
repression by transcription factor occupancy.
Among the 8,002 and 4,915 TAL1 peaks called in G1E
and G1E-ER4 cell lines [15], respectively, we obtained
7,049 differential peaks (DPs) of TAL1 as determined by
the unique binding sites called in each of the two cell
lines (i.e., the binary method). In comparison, we ran
dCaP-T2 on the union of TAL1 peaks from the two cell
lines. At a FDR 10% threshold, dCaP reported 3,249
DPs of TAL1. We then compared the results between
dCaP-T2 and the binary method.
By intersecting the DPs from dCaP and the binary calls,
we assigned the DPs into three categories: (A) DPs only
called by the binary method (binary-only); (B) DPs only
called by dCaP (cap-only); and (C) DPs called by both
methods (common). The Venn diagram of these DPs is
shown in Figure 7A. There are many more DPs called by
the binary method (7,049) than by dCaP (3,249). We
observed that 85% of the DPs by dCaP agreed with the
DPs by binary intersection, and 40% of the DPs by the bin-
ary method agreed with the DPs by dCaP.
To evaluate the TAL1 DPs in the three categories, we
generated a scatter plot showing the binding signals of all
TAL1 occupancy (Figure 7B) and a boxplot of their abso-
lute binding differences (Figure 7C) between the two cell
lines, for each of the three groups of DPs. Figure 7B shows
that most of the binary-only DPs are distributed along the
diagonal line and many of them tend to have lower bind-
ing signals in both cell lines compared to the other two
DP groups. Figure 7C further shows that the DPs in the
binary-only group have the least binding variation between
G1E and G1E-ER4. In fact, most (95%) of the binary-only
DPs had TAL1 peaks identified in G1E but not in ER4.
When considering the magnitude of binding signals
instead of the binary peak calls, however, only 77% of the
binary-only DPs showed stronger TAL1 signals in G1E
than in ER4. This inconsistency is created by calling peaks
in each cell line separately. In addition, around 70% of the
binary-only DPs are the weaker binding events with log2
signals <2. Therefore, these DPs were not considered as
differential occupancy by dCaP after taking the signal
magnitude into account.
In contrast to the binary-only DPs, the cap-only DPs
showed significant signal variations. The cap-only DPs
were missed by the binary method because they were
Figure 7 Comparison of differential binding detected by
intersection of binary peaks and dCaP. (A) Venn diagram of TAL1
DPs in the three categories. (B) Scatter plot of the log2 TAL1
binding signals in the merged binding peaks (C) Boxplot of the
absolute binding difference in G1E and G1E-ER4 cell lines for the
three groups of DPs.
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called as binding in both cell lines. In total, we detected
463 cap-only DPs, which accounted for 16% of TAL1
“common” binding in G1E and G1E-ER4 by the binary
method. In contrast to the 77% for binary-only DPs, only
40% of the cap-only DPs had stronger binding signals in
G1E than in ER4. As a reference, among the common
DPs detected by both methods, 38% of common DPs had
stronger signals in G1E than in ER4. Therefore, the per-
centage of cap-only DPs is very close to percentage
observed in the common DPs. In addition, the binding
variation of cap-only DPs is much larger than that of the
binary-only DPs, and is similar to the binding variation of
common DPs (Figure 7C).
We further intersected the DPs in the three groups with
relevant biological features to explore their functional
importance, including features relevant to TAL1 differen-
tial occupancy, such as GATA1 binding in G1E-ER4, dif-
ferentially expressed genes (between G1E and G1E-ER4),
SNPs, and features not relevant to TAL1 differential occu-
pancy, such as non-differentially expressed genes and CpG
islands. We expect that the true TAL1 DPs should be
highly overlapping with the features relevant to TAL1 dif-
ferential occupancy, but not so with the irrelevant features.
Table 1 summarizes the proportions of TAL1 DPs in the
three categories overlapping with different biological fea-
tures. We found that the proportions of overlaps for cap-
only and binary-only DPs are significantly different (fish-
er’s exact test) only in features relevant to TAL1 differen-
tial occupancy, such as induced genes, differentially
expressed genes, SNPs (dbSNP128), GATA1 binding
peaks and GATA1 motifs. In particular, the proportions of
overlaps for cap-only DPs are consistently higher than
those for the binary-only group. The unequal proportions
of overlaps among groups are unlikely to be random, espe-
cially because there is no significant difference in the pro-
portions of overlaps for features irrelevant to the TAL1
DPs (e.g. non-differential expressed genes and CpG
islands). These findings suggest that dCaP is more accu-
rate in detecting true TAL1 differential occupancy than
the binary method.
In summary, our results indicate that it is important to
consider quantitative variation when studying differential
regulation. The cap-only DPs were not detected by the
binary method because they were called as peaks in both
cell lines, despite of the fact that they demonstrated signif-
icant signal variation that may have important indication
of biological functions.
Conclusions
We have proposed a new powerful method called dCaP
that incorporates the quantitative information of multi-
ple epigenetic features to detect both constitutive and
variational protein-DNA interaction events in multiple
conditions. Given that epigenetic features are highly cor-
related, the combinatorial effects of multiple proteins
may only be detectable using a joint approach, i.e., the
signal variation of one factor may only be observable by
conditioning on the data of other factors. The variance of
binding signals is frequently heterogeneous for different
factors at different genomic positions. To gain power, we
estimated the variances of noise as a function of the
means within each pair of condition and factor using
local smoothing techniques. We explicitly used replicates
to estimate binding variances. If there are no replicates,
we can utilize data across conditions to estimate the var-
iances for each factor. We then designed a 3-step log
likelihood ratio test to detect joint, differential, and con-
dition-specific events in a multi-cellular context. The log
likelihood ratios generated in each condition can also be
used to quantify the contribution of each condition to
the total variations. When binding regions are available,
instead of running all 3 tests, one can directly apply
dCaP-Test2 and dCaP-Test3 on the binding peaks to test
the differential and condition-specific binding.
In an application to human ENCODE data set, we
detected cell-type specific regulatory regions that mainly
demonstrated two patterns: all signals are either enriched
or depleted. In general, this may depend on the factors
being studied. The cell-type specific enriched regions were
strongly associated with functional terms, pathways and
diseases relevant to the corresponding cell types. In con-
trast, the cell-type specific depleted regions, particularly in
cancer cell lines, were strongly associated with the CNVs.
Among those depleted regions overlapping with homozy-
gous deletions, approximately 97.8% were from the three
cancer cell lines, and over 90.7% were found in K562
alone. Similarly, 99.6% of the enriched regions with ampli-
fication CNVs were in the three cancer cell lines, with
40.9 % in HepG2, 40.3% in K562, and 18.28% in HeLa-S3.
Our results suggest that the cell-type specific depleted sig-
nals in cancer cell lines may be under genomic alterations
and can be located near genes associated with different
types of cancer (i.e. FHIT, STK11, CDKN2A, CDKN2B).
Other possible causes for the depletion of signals may
include genetic mutations, alternative promoters, and epi-
genetic silencing through methylation that leads to aber-
rant silencing of normal tumor-suppressor function in
cancer cell lines [48]. While we detected many cell-type
specific regulatory regions showing consistent binding pat-
terns near a target gene, we also observed some loci near a
target gene showing complementary binding patterns. The
latter may suggest binding turnover or alternative promo-
ters that are recognized for creating transcript diversity in
a cell. To explore the functional consequences of different
binding patterns within a local region, future work could
incorporate RNA-Seq data into consideration.
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In a second application to TAL1 occupancy in response
to GATA1 restoration in mouse erythroid cell lines, dCaP
detected a unique set of TAL1 differential occupancy sites
that were missed by the binary method by Wu et al. (6).
Those sites were called in both G1E and G1E-ER4 cells as
occupant, yet their binding signals were significantly dif-
ferent. Such quantitative variation is only detectable when
considering the magnitude of binding rather than binary
presence or absence calls. On the other hand, there were a
large portion of “differential binding” called by the binary
method alone, which were likely false positives given their
small differences in the magnitude of binding between the
two cell lines. By further overlapping the DPs with biologi-
cal features, we observed that the dCaP-only DPs were
highly enriched near differentially expressed genes and
GATA1 binding sites, while the enrichments for the bin-
ary-only DPs were much less significant.
ChIP-seq data is being rapidly generated not only for
many TFs and epigenetic marks, but also in multiple con-
ditions, tissues, cell types, and individuals. Using dCaP,
both constitutive and variational regulatory regions can be
powerfully detected by integrating information in a statisti-
cally consistent and efficient way. After finding significant
loci of differential regulation and cell-type specificity, the
users can intersect the loci with other biological data and
functional annotations to derive hypotheses. Clustering
analysis of the patterns of signals followed by functional
enrichment analysis can also help elucidating the dynamic
epigenetic landscapes underlying regulation in multi-cellu-
lar contexts. Besides clustering, one can use unsupervised
methods like PCA analysis to explore the binding pattern
across conditions. PCA loadings can be further used to
identify leading factors that contribute most to the differ-
ence in the overall binding patterns. As the number of data
tracks under comparison increase, directly apply unsuper-
vised methods may not be a good way since they do not
provide statistical significance, the increasing noises may
confuse clustering results, and PCA does not directly detect
differential signals. Our approach is flexible and general.
The users can define their own sets of factors and condi-
tions of interest and apply dCaP in a similar way as used in
this study. For example, TF binding variations can be
detected among individuals by treating each individual as a
“condition”. Association between epigenetic factors and
disease phenotypes can be directly tested by treating
groups of individuals with the same phenotype as “condi-
tions” and individuals within groups as “replicates”.
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